N-3 polyunsaturated fatty acid consumption produces neurobiological effects associated with prevention of depression in rats after the forced swimming test

Journal of Nutritional Biochemistry

Volumn 23, Issue 8, 2012, Pages 924-928

  Park, Yongsoon ^a   Moon, Hyoun Jung ^a   Kim, Seok Hyeon ^a  

^a Hanyang University   (South Korea)

Author keywords

BDNF; CREB; Cytokines; Depression; Forced swimming test; N 3 polyunsaturated fatty acids

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; OMEGA 3 FATTY ACID; PHOSPHOLIPID; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BODY WEIGHT; CALORIC INTAKE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; DISEASE ASSOCIATION; DOSE RESPONSE; FOOD INTAKE; FORCED SWIMMING TEST; HIPPOCAMPUS; IMMOBILIZATION; MALE; NEUROBIOLOGY; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SEROTONIN BLOOD LEVEL; TREATMENT DURATION;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSION; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; SWIMMING; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84864002328     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.04.018     Document Type: Article

References (37)

1. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 2010, 68:140-147.
2. Clayton E.H., Hanstock T.L., Hirneth S.J., Kable C.J., Garg M.L., Hazell P.L. Reduced mania and depression in juvenile bipolar disorder associated with long-chain x-3 polyunsaturated fatty acid supplementation. Eur J Clin Nutr 2009, 63:1037-1040.
3. McNamara R.K., Jandacek R., Rider T., Tso P., Dwivedi Y., Pandey G.N. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affec Dis 2010, 126:303-311.
4. Baghai T.C., Varallo-Bedarida G., Born C., Häfner S., Schüle C., Eser D., Rupprecht R., Bondy B., von Schacky C. Major depressive disorder is associated with cardiovascular risk factors and low omega-3 index. J Clin Psychiatry 2010, [Epub ahead of print].
5. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys Acta 2000, 1486:219-231.
6. Cartwright I.J., Pockley A.G., Galloway J.H., Greaves M., Preston F.E. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 1985, 55(3):267-281.
7. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S.
8. James M.J., Cleland L.G. Dietary n-3 fatty acids and therapy for rheumatoid arthritis. Semin Arthritis Rheum 1997, 27:85-97.
9. Logan A.C. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 2003, 8(4):410-425.
10. Rao J.S., Ertley R.N., Lee H.J., DeMar J.C., Arnold J.T., Rapoport S.I., Bazinet R.P. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 2007, 12(1):36-46.
11. DeMar J.C., Ma K., Bell J.M., Igarashi M., Greenstein D., Rapoport S.I. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J Lipid Res 2006, 47(1):172-180.
12. Aid S., Vancassel S., Poumes-Ballihaut C., Chalon S., Guesnet P., Lavialle M. Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 2003, 44:1545-1551.
13. Takeuchi T., Fukumoto Y., Harada E. Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat. Behav Brain Res 2002, 131:193-203.
14. Carlezon W.A., Mague S.D., Parow A.M., Stoll A.L., Cohen B.M., Renshaw P.F. Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats. Biol Psychiatry 2005, 57(4):343-350.
15. Huang S.Y., Yang H.T., Chiu C.C., Pariante C.M., Su K.P. Omega-3 fatty acids on the forced-swimming test. J Psychiatr Res 2008, 42(1):58-63.
16. Venna V.R., Deplanque D., Allet C., Belarbi K., Hamdane M., Bordet R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009, 34(2):199-211.
17. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9:609-620.
18. Sapolsky R.M. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000, 48:755-765.
19. Detke M.J., Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 1996, 73(1-2):43-46.
20. Harris W.S., Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease. Prev Med 2004, 39:212-220.
21. Adams P.B., Lawson S., Sanigorski A., Sinclair A.J. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids 1996, 31:S157-S161.
22. Maes M., Christophe A., Delanghe J., Altamura C., Neels H., Meltzer H.Y. Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res 1999, 85:275-291.
23. Su K.P., Huang S.Y., Chiu C.C., Shen W.W. Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 2003, 13:267-271.
24. Lucas M., Asselin G., Mérette C., Poulin M.J., Dodin S. Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial. Am J Clin Nutr 2009, 89:641-651.
25. Shaldubina A., Nemets B., Bersudsky Y. Lack of effect of eicosapentaenoic acid in the Porsolt forced swimming test model of depression. Acta Neuropsychiatrica 2002, 14:203-206.
26. du Bois T.M., Deng C., Bell W., Huang X.F. Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience 2006, 139:1397-1403.
27. Delion S., Chalon S., Guilloteau D., Lejeune B., Besnard J.C., Durand G. Age-related changes in phospholipid fatty acid composition and monoaminergic neurotransmission in the hippocampus of rats fed a balanced or an n-3 polyunsaturated fatty acid-deficient diet. J Lipid Res 1997, 38:680-689.
28. Garcia M.C., Kim H.Y. Mobilization of arachidonate and decosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res 1997, 768:43-48.
29. McNamara R.K., Able J., Liu Y., Jandacek R., Rider T., Tso P., Lipton J.W. Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects. J Psychiatr Res 2009, 43(6):656-663.
30. Hibbeln J.R., Linnoila M., Umhau J.C., Rawlings R., George D.T., Salem N. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics. Biol Psychiatry 1998, 44:235-242.
31. Risch S.C., Nemeroff C.B. Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry 1992, 53:3S-7S.
32. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004, 56:819-824.
33. Nomura T., Nishizaki T., Enomoto T., Itoh H. A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A2 signaling pathway. Life Sci 2001, 68(25):2885-2891.
34. Levant B., Ozias M.K., Davis P.F., Winter M., Russell K.L., Carlson S.E., Reed G.A., McCarson K.E. Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: interactions with reproductive status in female rats. Psychoneuroendocrinology 2008, 33(9):1279-1292.
35. Lieb J., Karmali R., Horrobin D. Elevated levels of prostaglandin E2 and thromboxane B2 in depression. Prostaglandins Leukot Med 1983, 10:361-367.
36. Nishino S., Ueno R., Ohishi K., Sakai T., Hayaishi O. Salivary prostaglandin concentrations: possible state indicators for major depression. Am J Psychiatry 1989, 146:365-368.
37. Blendy J.A. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006, 59:1144-1150.